The global Tumor Diagnosis Solutions market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Tumor Diagnosis Solutions is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tumor Diagnosis Solutions is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Tumor Diagnosis Solutions in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Tumor Diagnosis Solutions include Dian Diagnostics Group, Sansure Biotech, YHLO Biotech, Thermo Fisher Scientific, Amoy Diagnostics, Ibex, Elephas, Philips Healthcare and Lepu Medical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tumor Diagnosis Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Diagnosis Solutions.

Report Scope

The Tumor Diagnosis Solutions market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tumor Diagnosis Solutions market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tumor Diagnosis Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tumor Diagnosis Solutions Market Report

Report Metric	Details
Report Name	Tumor Diagnosis Solutions Market
Segment by Type	Lung Cancer Diagnostic Services Breast Cancer Diagnostic Services Kidney Cancer Diagnostic Services Other
Segment by Application	Hospital Clinic Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Dian Diagnostics Group, Sansure Biotech, YHLO Biotech, Thermo Fisher Scientific, Amoy Diagnostics, Ibex, Elephas, Philips Healthcare, Lepu Medical, Epredia, Roche, Caris Life Sciences, NeoGenomics, OncoDNA, Kheiron, Abbott, Mirada Medical, GuardantHealth, Labcorp
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Diagnosis Solutions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Diagnosis Solutions Market report?

Ans: The main players in the Tumor Diagnosis Solutions Market are Dian Diagnostics Group, Sansure Biotech, YHLO Biotech, Thermo Fisher Scientific, Amoy Diagnostics, Ibex, Elephas, Philips Healthcare, Lepu Medical, Epredia, Roche, Caris Life Sciences, NeoGenomics, OncoDNA, Kheiron, Abbott, Mirada Medical, GuardantHealth, Labcorp

What are the Application segmentation covered in the Tumor Diagnosis Solutions Market report?

Ans: The Applications covered in the Tumor Diagnosis Solutions Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Tumor Diagnosis Solutions Market report?

Ans: The Types covered in the Tumor Diagnosis Solutions Market report are Lung Cancer Diagnostic Services, Breast Cancer Diagnostic Services, Kidney Cancer Diagnostic Services, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tumor Diagnosis Solutions Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Lung Cancer Diagnostic Services

1.2.3 Breast Cancer Diagnostic Services

1.2.4 Kidney Cancer Diagnostic Services

1.2.5 Other

1.3 Market by Application

1.3.1 Global Tumor Diagnosis Solutions Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tumor Diagnosis Solutions Market Perspective (2019-2030)

2.2 Tumor Diagnosis Solutions Growth Trends by Region

2.2.1 Global Tumor Diagnosis Solutions Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Tumor Diagnosis Solutions Historic Market Size by Region (2019-2024)

2.2.3 Tumor Diagnosis Solutions Forecasted Market Size by Region (2025-2030)

2.3 Tumor Diagnosis Solutions Market Dynamics

2.3.1 Tumor Diagnosis Solutions Industry Trends

2.3.2 Tumor Diagnosis Solutions Market Drivers

2.3.3 Tumor Diagnosis Solutions Market Challenges

2.3.4 Tumor Diagnosis Solutions Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tumor Diagnosis Solutions Players by Revenue

3.1.1 Global Top Tumor Diagnosis Solutions Players by Revenue (2019-2024)

3.1.2 Global Tumor Diagnosis Solutions Revenue Market Share by Players (2019-2024)

3.2 Global Tumor Diagnosis Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Tumor Diagnosis Solutions Revenue

3.4 Global Tumor Diagnosis Solutions Market Concentration Ratio

3.4.1 Global Tumor Diagnosis Solutions Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tumor Diagnosis Solutions Revenue in 2023

3.5 Tumor Diagnosis Solutions Key Players Head office and Area Served

3.6 Key Players Tumor Diagnosis Solutions Product Solution and Service

3.7 Date of Enter into Tumor Diagnosis Solutions Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Diagnosis Solutions Breakdown Data by Type

4.1 Global Tumor Diagnosis Solutions Historic Market Size by Type (2019-2024)

4.2 Global Tumor Diagnosis Solutions Forecasted Market Size by Type (2025-2030)

5 Tumor Diagnosis Solutions Breakdown Data by Application

5.1 Global Tumor Diagnosis Solutions Historic Market Size by Application (2019-2024)

5.2 Global Tumor Diagnosis Solutions Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Tumor Diagnosis Solutions Market Size (2019-2030)

6.2 North America Tumor Diagnosis Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Tumor Diagnosis Solutions Market Size by Country (2019-2024)

6.4 North America Tumor Diagnosis Solutions Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tumor Diagnosis Solutions Market Size (2019-2030)

7.2 Europe Tumor Diagnosis Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Tumor Diagnosis Solutions Market Size by Country (2019-2024)

7.4 Europe Tumor Diagnosis Solutions Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tumor Diagnosis Solutions Market Size (2019-2030)

8.2 Asia-Pacific Tumor Diagnosis Solutions Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Tumor Diagnosis Solutions Market Size by Region (2019-2024)

8.4 Asia-Pacific Tumor Diagnosis Solutions Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tumor Diagnosis Solutions Market Size (2019-2030)

9.2 Latin America Tumor Diagnosis Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Tumor Diagnosis Solutions Market Size by Country (2019-2024)

9.4 Latin America Tumor Diagnosis Solutions Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tumor Diagnosis Solutions Market Size (2019-2030)

10.2 Middle East & Africa Tumor Diagnosis Solutions Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Tumor Diagnosis Solutions Market Size by Country (2019-2024)

10.4 Middle East & Africa Tumor Diagnosis Solutions Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Dian Diagnostics Group

11.1.1 Dian Diagnostics Group Company Detail

11.1.2 Dian Diagnostics Group Business Overview

11.1.3 Dian Diagnostics Group Tumor Diagnosis Solutions Introduction

11.1.4 Dian Diagnostics Group Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.1.5 Dian Diagnostics Group Recent Development

11.2 Sansure Biotech

11.2.1 Sansure Biotech Company Detail

11.2.2 Sansure Biotech Business Overview

11.2.3 Sansure Biotech Tumor Diagnosis Solutions Introduction

11.2.4 Sansure Biotech Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.2.5 Sansure Biotech Recent Development

11.3 YHLO Biotech

11.3.1 YHLO Biotech Company Detail

11.3.2 YHLO Biotech Business Overview

11.3.3 YHLO Biotech Tumor Diagnosis Solutions Introduction

11.3.4 YHLO Biotech Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.3.5 YHLO Biotech Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Detail

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Tumor Diagnosis Solutions Introduction

11.4.4 Thermo Fisher Scientific Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Amoy Diagnostics

11.5.1 Amoy Diagnostics Company Detail

11.5.2 Amoy Diagnostics Business Overview

11.5.3 Amoy Diagnostics Tumor Diagnosis Solutions Introduction

11.5.4 Amoy Diagnostics Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.5.5 Amoy Diagnostics Recent Development

11.6 Ibex

11.6.1 Ibex Company Detail

11.6.2 Ibex Business Overview

11.6.3 Ibex Tumor Diagnosis Solutions Introduction

11.6.4 Ibex Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.6.5 Ibex Recent Development

11.7 Elephas

11.7.1 Elephas Company Detail

11.7.2 Elephas Business Overview

11.7.3 Elephas Tumor Diagnosis Solutions Introduction

11.7.4 Elephas Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.7.5 Elephas Recent Development

11.8 Philips Healthcare

11.8.1 Philips Healthcare Company Detail

11.8.2 Philips Healthcare Business Overview

11.8.3 Philips Healthcare Tumor Diagnosis Solutions Introduction

11.8.4 Philips Healthcare Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.8.5 Philips Healthcare Recent Development

11.9 Lepu Medical

11.9.1 Lepu Medical Company Detail

11.9.2 Lepu Medical Business Overview

11.9.3 Lepu Medical Tumor Diagnosis Solutions Introduction

11.9.4 Lepu Medical Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.9.5 Lepu Medical Recent Development

11.10 Epredia

11.10.1 Epredia Company Detail

11.10.2 Epredia Business Overview

11.10.3 Epredia Tumor Diagnosis Solutions Introduction

11.10.4 Epredia Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.10.5 Epredia Recent Development

11.11 Roche

11.11.1 Roche Company Detail

11.11.2 Roche Business Overview

11.11.3 Roche Tumor Diagnosis Solutions Introduction

11.11.4 Roche Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.11.5 Roche Recent Development

11.12 Caris Life Sciences

11.12.1 Caris Life Sciences Company Detail

11.12.2 Caris Life Sciences Business Overview

11.12.3 Caris Life Sciences Tumor Diagnosis Solutions Introduction

11.12.4 Caris Life Sciences Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.12.5 Caris Life Sciences Recent Development

11.13 NeoGenomics

11.13.1 NeoGenomics Company Detail

11.13.2 NeoGenomics Business Overview

11.13.3 NeoGenomics Tumor Diagnosis Solutions Introduction

11.13.4 NeoGenomics Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.13.5 NeoGenomics Recent Development

11.14 OncoDNA

11.14.1 OncoDNA Company Detail

11.14.2 OncoDNA Business Overview

11.14.3 OncoDNA Tumor Diagnosis Solutions Introduction

11.14.4 OncoDNA Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.14.5 OncoDNA Recent Development

11.15 Kheiron

11.15.1 Kheiron Company Detail

11.15.2 Kheiron Business Overview

11.15.3 Kheiron Tumor Diagnosis Solutions Introduction

11.15.4 Kheiron Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.15.5 Kheiron Recent Development

11.16 Abbott

11.16.1 Abbott Company Detail

11.16.2 Abbott Business Overview

11.16.3 Abbott Tumor Diagnosis Solutions Introduction

11.16.4 Abbott Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.16.5 Abbott Recent Development

11.17 Mirada Medical

11.17.1 Mirada Medical Company Detail

11.17.2 Mirada Medical Business Overview

11.17.3 Mirada Medical Tumor Diagnosis Solutions Introduction

11.17.4 Mirada Medical Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.17.5 Mirada Medical Recent Development

11.18 GuardantHealth

11.18.1 GuardantHealth Company Detail

11.18.2 GuardantHealth Business Overview

11.18.3 GuardantHealth Tumor Diagnosis Solutions Introduction

11.18.4 GuardantHealth Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.18.5 GuardantHealth Recent Development

11.19 Labcorp

11.19.1 Labcorp Company Detail

11.19.2 Labcorp Business Overview

11.19.3 Labcorp Tumor Diagnosis Solutions Introduction

11.19.4 Labcorp Revenue in Tumor Diagnosis Solutions Business (2019-2024)

11.19.5 Labcorp Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Dian Diagnostics Group

List of Tables

Table 1. Global Tumor Diagnosis Solutions Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Lung Cancer Diagnostic Services

Table 3. Key Players of Breast Cancer Diagnostic Services

Table 4. Key Players of Kidney Cancer Diagnostic Services

Table 5. Key Players of Other

Table 6. Global Tumor Diagnosis Solutions Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Tumor Diagnosis Solutions Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Tumor Diagnosis Solutions Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Tumor Diagnosis Solutions Market Share by Region (2019-2024)

Table 10. Global Tumor Diagnosis Solutions Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Tumor Diagnosis Solutions Market Share by Region (2025-2030)

Table 12. Tumor Diagnosis Solutions Market Trends

Table 13. Tumor Diagnosis Solutions Market Drivers

Table 14. Tumor Diagnosis Solutions Market Challenges

Table 15. Tumor Diagnosis Solutions Market Restraints

Table 16. Global Tumor Diagnosis Solutions Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Tumor Diagnosis Solutions Market Share by Players (2019-2024)

Table 18. Global Top Tumor Diagnosis Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Diagnosis Solutions as of 2023)

Table 19. Ranking of Global Top Tumor Diagnosis Solutions Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Tumor Diagnosis Solutions Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Tumor Diagnosis Solutions Product Solution and Service

Table 23. Date of Enter into Tumor Diagnosis Solutions Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Tumor Diagnosis Solutions Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Tumor Diagnosis Solutions Revenue Market Share by Type (2019-2024)

Table 27. Global Tumor Diagnosis Solutions Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Tumor Diagnosis Solutions Revenue Market Share by Type (2025-2030)

Table 29. Global Tumor Diagnosis Solutions Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Tumor Diagnosis Solutions Revenue Market Share by Application (2019-2024)

Table 31. Global Tumor Diagnosis Solutions Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Tumor Diagnosis Solutions Revenue Market Share by Application (2025-2030)

Table 33. North America Tumor Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Tumor Diagnosis Solutions Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Tumor Diagnosis Solutions Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Tumor Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Tumor Diagnosis Solutions Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Tumor Diagnosis Solutions Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Tumor Diagnosis Solutions Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Tumor Diagnosis Solutions Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Tumor Diagnosis Solutions Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Tumor Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Tumor Diagnosis Solutions Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Tumor Diagnosis Solutions Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Tumor Diagnosis Solutions Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Tumor Diagnosis Solutions Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Tumor Diagnosis Solutions Market Size by Country (2025-2030) & (US$ Million)

Table 48. Dian Diagnostics Group Company Detail

Table 49. Dian Diagnostics Group Business Overview

Table 50. Dian Diagnostics Group Tumor Diagnosis Solutions Product

Table 51. Dian Diagnostics Group Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 52. Dian Diagnostics Group Recent Development

Table 53. Sansure Biotech Company Detail

Table 54. Sansure Biotech Business Overview

Table 55. Sansure Biotech Tumor Diagnosis Solutions Product

Table 56. Sansure Biotech Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 57. Sansure Biotech Recent Development

Table 58. YHLO Biotech Company Detail

Table 59. YHLO Biotech Business Overview

Table 60. YHLO Biotech Tumor Diagnosis Solutions Product

Table 61. YHLO Biotech Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 62. YHLO Biotech Recent Development

Table 63. Thermo Fisher Scientific Company Detail

Table 64. Thermo Fisher Scientific Business Overview

Table 65. Thermo Fisher Scientific Tumor Diagnosis Solutions Product

Table 66. Thermo Fisher Scientific Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 67. Thermo Fisher Scientific Recent Development

Table 68. Amoy Diagnostics Company Detail

Table 69. Amoy Diagnostics Business Overview

Table 70. Amoy Diagnostics Tumor Diagnosis Solutions Product

Table 71. Amoy Diagnostics Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 72. Amoy Diagnostics Recent Development

Table 73. Ibex Company Detail

Table 74. Ibex Business Overview

Table 75. Ibex Tumor Diagnosis Solutions Product

Table 76. Ibex Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 77. Ibex Recent Development

Table 78. Elephas Company Detail

Table 79. Elephas Business Overview

Table 80. Elephas Tumor Diagnosis Solutions Product

Table 81. Elephas Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 82. Elephas Recent Development

Table 83. Philips Healthcare Company Detail

Table 84. Philips Healthcare Business Overview

Table 85. Philips Healthcare Tumor Diagnosis Solutions Product

Table 86. Philips Healthcare Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 87. Philips Healthcare Recent Development

Table 88. Lepu Medical Company Detail

Table 89. Lepu Medical Business Overview

Table 90. Lepu Medical Tumor Diagnosis Solutions Product

Table 91. Lepu Medical Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 92. Lepu Medical Recent Development

Table 93. Epredia Company Detail

Table 94. Epredia Business Overview

Table 95. Epredia Tumor Diagnosis Solutions Product

Table 96. Epredia Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 97. Epredia Recent Development

Table 98. Roche Company Detail

Table 99. Roche Business Overview

Table 100. Roche Tumor Diagnosis Solutions Product

Table 101. Roche Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 102. Roche Recent Development

Table 103. Caris Life Sciences Company Detail

Table 104. Caris Life Sciences Business Overview

Table 105. Caris Life Sciences Tumor Diagnosis Solutions Product

Table 106. Caris Life Sciences Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 107. Caris Life Sciences Recent Development

Table 108. NeoGenomics Company Detail

Table 109. NeoGenomics Business Overview

Table 110. NeoGenomics Tumor Diagnosis Solutions Product

Table 111. NeoGenomics Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 112. NeoGenomics Recent Development

Table 113. OncoDNA Company Detail

Table 114. OncoDNA Business Overview

Table 115. OncoDNA Tumor Diagnosis Solutions Product

Table 116. OncoDNA Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 117. OncoDNA Recent Development

Table 118. Kheiron Company Detail

Table 119. Kheiron Business Overview

Table 120. Kheiron Tumor Diagnosis Solutions Product

Table 121. Kheiron Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 122. Kheiron Recent Development

Table 123. Abbott Company Detail

Table 124. Abbott Business Overview

Table 125. Abbott Tumor Diagnosis Solutions Product

Table 126. Abbott Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 127. Abbott Recent Development

Table 128. Mirada Medical Company Detail

Table 129. Mirada Medical Business Overview

Table 130. Mirada Medical Tumor Diagnosis Solutions Product

Table 131. Mirada Medical Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 132. Mirada Medical Recent Development

Table 133. GuardantHealth Company Detail

Table 134. GuardantHealth Business Overview

Table 135. GuardantHealth Tumor Diagnosis Solutions Product

Table 136. GuardantHealth Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 137. GuardantHealth Recent Development

Table 138. Labcorp Company Detail

Table 139. Labcorp Business Overview

Table 140. Labcorp Tumor Diagnosis Solutions Product

Table 141. Labcorp Revenue in Tumor Diagnosis Solutions Business (2019-2024) & (US$ Million)

Table 142. Labcorp Recent Development

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tumor Diagnosis Solutions Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Tumor Diagnosis Solutions Market Share by Type: 2023 VS 2030

Figure 3. Lung Cancer Diagnostic Services Features

Figure 4. Breast Cancer Diagnostic Services Features

Figure 5. Kidney Cancer Diagnostic Services Features

Figure 6. Other Features

Figure 7. Global Tumor Diagnosis Solutions Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Tumor Diagnosis Solutions Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Other Case Studies

Figure 12. Tumor Diagnosis Solutions Report Years Considered

Figure 13. Global Tumor Diagnosis Solutions Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Tumor Diagnosis Solutions Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Tumor Diagnosis Solutions Market Share by Region: 2023 VS 2030

Figure 16. Global Tumor Diagnosis Solutions Market Share by Players in 2023

Figure 17. Global Top Tumor Diagnosis Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Diagnosis Solutions as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Tumor Diagnosis Solutions Revenue in 2023

Figure 19. North America Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Tumor Diagnosis Solutions Market Share by Country (2019-2030)

Figure 21. United States Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Tumor Diagnosis Solutions Market Share by Country (2019-2030)

Figure 25. Germany Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Tumor Diagnosis Solutions Market Share by Region (2019-2030)

Figure 33. China Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Tumor Diagnosis Solutions Market Share by Country (2019-2030)

Figure 41. Mexico Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Tumor Diagnosis Solutions Market Share by Country (2019-2030)

Figure 45. Turkey Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Tumor Diagnosis Solutions Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Dian Diagnostics Group Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 48. Sansure Biotech Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 49. YHLO Biotech Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 51. Amoy Diagnostics Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 52. Ibex Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 53. Elephas Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 54. Philips Healthcare Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 55. Lepu Medical Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 56. Epredia Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 57. Roche Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 58. Caris Life Sciences Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 59. NeoGenomics Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 60. OncoDNA Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 61. Kheiron Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 62. Abbott Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 63. Mirada Medical Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 64. GuardantHealth Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 65. Labcorp Revenue Growth Rate in Tumor Diagnosis Solutions Business (2019-2024)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26D6003

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Global Chemotherapy Chairs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-26D13514

Sat Oct 12 00:00:00 UTC 2024

Add to Cart

Drugs for Non-Small Cell Lung Cancer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-33S12067

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Anti-Oral Mucositis Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5V5924

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Tumor Diagnosis Solutions Market Research Report 2024

Published Date: July 2024

Report Code: QYRE-Auto-21H12722

Global Tumor Diagnosis Solutions Market Research Report 2024

FEATURED COMPANIES

Tumor Diagnosis Solutions Market

Report Scope

Scope of Tumor Diagnosis Solutions Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Tumor Diagnosis Solutions Market report?

What are the Application segmentation covered in the Tumor Diagnosis Solutions Market report?

What are the Type segmentation covered in the Tumor Diagnosis Solutions Market report?

FEATURED COMPANIES

RELATED REPORTS